Celadon Partners SPV 24 bought SNTI
March 10, 2025 · Form 4 insider transaction
Celadon Partners SPV 24 bought 9,777,000 shares of Senti Biosciences Holdings, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,777,000
Price
N/A
Total value
N/A
InsiderCeladon Partners SPV 24
Role—
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateMarch 10, 2025
Filing dateMarch 14, 2025
Shares owned after9,777,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of Series A Convertible Preferred Stock (the "Series A Preferred Stock") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 9,777,000 shares of Common Stock. The Series A Preferred Stock had no expiration date.